{
    "organizations": [],
    "uuid": "ce6f8bfcc24883e71a7f82f815a27e58440c57bd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abac-therapeutics-announces-16-mln/brief-abac-therapeutics-announces-16-mln-series-a-idUSASB0C5YE",
    "ord_in_thread": 0,
    "title": "BRIEF-ABAC Therapeutics Announces €16 Mln Series A",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - ABAC Therapeutics:\n* ABAC THERAPEUTICS ANNOUNCES €16 MILLION SERIES A TO DEVELOP THERAPEUTIC SOLUTIONS TO FIGHT ANTIBIOTIC-RESISTANT BACTERIA\n* ABAC THERAPEUTICS SAYS FINANCING WAS LED BY PONTIFAX Source text for Eikon:\n ",
    "published": "2018-02-15T21:19:00.000+02:00",
    "crawled": "2018-02-16T16:41:25.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "abac",
        "therapeutic",
        "abac",
        "therapeutic",
        "announces",
        "million",
        "series",
        "develop",
        "therapeutic",
        "solution",
        "fight",
        "bacteria",
        "abac",
        "therapeutic",
        "say",
        "financing",
        "led",
        "pontifax",
        "source",
        "text",
        "eikon"
    ]
}